I'rom Group Co., Ltd. Stock

2372

JP3105170009

Healthcare Facilities & Services

OTC Markets Traded

Latest news: I'rom Group Co., Ltd.

25-03-25	I'rom Group Co Ltd - To Retire Treasury Shares Worth 1.89% Of Outstanding Stock On May 13	RE
25-03-13	I'rom Group Co., Ltd.(TSE:2372) dropped from S&P Global BMI Index	CI
25-03-05	BXJB II Holding Completes Tender Offer for I'rom Group Shares	MT
25-03-03	The Blackstone Group (HK) Limited completed the acquisition of 86.3% stake in I'rom Group Co., Ltd. from Toyotaka Mori and others.	CI
25-02-02	Blackstone's BXJB II Holding to Launch Tender Offer for I'rom Group	MT
24-12-22	BXJB II Holding KK to Launch Tender Offer for I'rom Group Shares	MT
24-05-30	GenoDive Pharma Inc announced that it has received funding from I'rom Group Co., Ltd.	CI
23-05-11	I'rom Group Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	CI
22-08-25	Lupin Ties Up with I'rom Group to Commercialize Denosumab in Japan	MT
22-08-25	Lupin and I'rom Enter into an Exclusive Licensing Agreement for Denosumab Biosimilar for Japan	CI
22-01-05	Cogsmart Co., Ltd. announced that it has received ¥350 million in funding from Omron Ventures Co., Ltd., I'rom Group Co., Ltd., DG Daiwa Ventures Inc., IT-Farm Corporation, Makoto Capital Co., Ltd. and other investors	CI
21-05-10	I'rom Group Co., Ltd. Announces Dividend for the Fiscal Year Ended March 31, 2021, Payable June 29, 2021 and Provided Dividend Guidance for the Second Quarter and Fiscal Year 2022	CI
20-02-05	I'rom Group Co., Ltd. Reports Consolidated Earnings Results for the Nine Months Ended December 2019; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 2020; Provides Year End Dividend for the Year Ending March 31, 2020	CI

More news

Press Releases: I'rom Group Co., Ltd.

24-12-20	Blackstone acquisition of clinical trial service provider not opposed, subject to divestiture of Australian subsidiary	AQ
24-11-07	Blackstone's proposed acquisition of I'rom raises concerns	AQ

More press releases

Managers and Directors: I'rom Group Co., Ltd.

Manager	Title	Age	Since
Akihiko Sugawara DFI	Director of Finance/CFO	58	2020-06-30
Toyotaka Mori PSD	President	67	1997-04-08
Tsugumine Shu CTO	Chief Tech/Sci/R&D Officer	68	2023-09-30

Director	Title	Age	Since
Kiyoshi Watanabe BRD	Director/Board Member	68	2011-05-31
Hiroaki Inukai BRD	Director/Board Member	60	2012-05-31
Masaaki Matsushima BRD	Director/Board Member	61	2013-05-31

More insiders

Medical & Diagnostic Laboratories

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
I'ROM GROUP CO., LTD.	-.--%	+0.04%	-	-	213M
CVS HEALTH CORPORATION	+1.14%	-3.68%	+7.93%	+27.73%	109B
HCA HEALTHCARE, INC.	+0.47%	+7.94%	+5.93%	+121.87%	105B
NATERA, INC.	-2.63%	-15.45%	+60.54%	+605.86%	46.46B
FRESENIUS SE & CO. KGAA	+2.05%	+8.03%	+10.16%	+105.72%	33.1B
LABCORP HOLDINGS INC.	-1.29%	+4.57%	+47.13%	+82.02%	30.19B
QUEST DIAGNOSTICS INCORPORATED	-0.83%	+3.53%	+44.66%	+97.26%	28.57B
TENET HEALTHCARE CORPORATION	+0.85%	+7.48%	+40.80%	+448.80%	23B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+0.23%	+2.73%	-17.74%	-17.68%	19.97B
IHH HEALTHCARE	+0.52%	-0.26%	-5.84%	+31.41%	16.76B
Average	+0.06%	+1.30%	+21.51%	+167.00%	46B
Weighted average by Cap.	+0.24%	+0.94%	+18.96%	+153.36%

See all sector performances

I'rom Group Co.,Ltd. is engaged in medical fields such as regenerative medicine and gene discovery. The Company operates through four business segments. The SMO segment provides support services for contracting or substituting a part of the work related to conducting clinical trials from the conducting medical institution. The CRO segment provides all or part of clinical trial operations from pharmaceutical companies and others. The Advanced Medicinal Treatment segment is engaged in the development of gene therapy products, the development, manufacture and sale of products in the field of regenerative medicine based on iPS cells related technologies, as well as the provision of contract manufacture services. The Medical Support segment provides general and comprehensive support for medical business management, such as setting up and renting clinic malls, selling products and related services. The Company also provides business utilizing IT infrastructure.

Employees

Sector

Healthcare Facilities & Services

More about the company